Literature DB >> 25082089

Toward a safer integration profile of MLV-based retroviral vectors.

Axel Schambach1.   

Abstract

Year:  2014        PMID: 25082089      PMCID: PMC4435597          DOI: 10.1038/mt.2014.124

Source DB:  PubMed          Journal:  Mol Ther        ISSN: 1525-0016            Impact factor:   11.454


× No keyword cloud information.
  20 in total

Review 1.  Retroviral DNA integration: HIV and the role of LEDGF/p75.

Authors:  Angela Ciuffi; Frederic D Bushman
Journal:  Trends Genet       Date:  2006-05-26       Impact factor: 11.639

2.  Gene therapy of X-linked severe combined immunodeficiency by use of a pseudotyped gammaretroviral vector.

Authors:  H Bobby Gaspar; Kathryn L Parsley; Steven Howe; Doug King; Kimberly C Gilmour; Joanna Sinclair; Gaby Brouns; Manfred Schmidt; Christof Von Kalle; Torben Barington; Marianne A Jakobsen; Hans O Christensen; Abdulaziz Al Ghonaium; Harry N White; John L Smith; Roland J Levinsky; Robin R Ali; Christine Kinnon; Adrian J Thrasher
Journal:  Lancet       Date:  2004 Dec 18-31       Impact factor: 79.321

3.  Human T-cell leukemia virus type 1 integration target sites in the human genome: comparison with those of other retroviruses.

Authors:  David Derse; Bruce Crise; Yuan Li; Gerald Princler; Nicole Lum; Claudia Stewart; Connor F McGrath; Stephen H Hughes; David J Munroe; Xiaolin Wu
Journal:  J Virol       Date:  2007-04-04       Impact factor: 5.103

4.  LEDGF hybrids efficiently retarget lentiviral integration into heterochromatin.

Authors:  Rik Gijsbers; Keshet Ronen; Sofie Vets; Nirav Malani; Jan De Rijck; Melissa McNeely; Frederic D Bushman; Zeger Debyser
Journal:  Mol Ther       Date:  2010-01-05       Impact factor: 11.454

5.  Gene therapy for immunodeficiency due to adenosine deaminase deficiency.

Authors:  Alessandro Aiuti; Federica Cattaneo; Stefania Galimberti; Ulrike Benninghoff; Barbara Cassani; Luciano Callegaro; Samantha Scaramuzza; Grazia Andolfi; Massimiliano Mirolo; Immacolata Brigida; Antonella Tabucchi; Filippo Carlucci; Martha Eibl; Memet Aker; Shimon Slavin; Hamoud Al-Mousa; Abdulaziz Al Ghonaium; Alina Ferster; Andrea Duppenthaler; Luigi Notarangelo; Uwe Wintergerst; Rebecca H Buckley; Marco Bregni; Sarah Marktel; Maria Grazia Valsecchi; Paolo Rossi; Fabio Ciceri; Roberto Miniero; Claudio Bordignon; Maria-Grazia Roncarolo
Journal:  N Engl J Med       Date:  2009-01-29       Impact factor: 91.245

6.  Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1.

Authors:  Marion G Ott; Manfred Schmidt; Kerstin Schwarzwaelder; Stefan Stein; Ulrich Siler; Ulrike Koehl; Hanno Glimm; Klaus Kühlcke; Andrea Schilz; Hana Kunkel; Sonja Naundorf; Andrea Brinkmann; Annette Deichmann; Marlene Fischer; Claudia Ball; Ingo Pilz; Cynthia Dunbar; Yang Du; Nancy A Jenkins; Neal G Copeland; Ursula Lüthi; Moustapha Hassan; Adrian J Thrasher; Dieter Hoelzer; Christof von Kalle; Reinhard Seger; Manuel Grez
Journal:  Nat Med       Date:  2006-04-02       Impact factor: 53.440

Review 7.  The LEDGF/p75 integrase interaction, a novel target for anti-HIV therapy.

Authors:  Frauke Christ; Zeger Debyser
Journal:  Virology       Date:  2013-01-05       Impact factor: 3.616

8.  BET proteins promote efficient murine leukemia virus integration at transcription start sites.

Authors:  Amit Sharma; Ross C Larue; Matthew R Plumb; Nirav Malani; Frances Male; Alison Slaughter; Jacques J Kessl; Nikolozi Shkriabai; Elizabeth Coward; Sriram S Aiyer; Patrick L Green; Li Wu; Monica J Roth; Frederic D Bushman; Mamuka Kvaratskhelia
Journal:  Proc Natl Acad Sci U S A       Date:  2013-07-01       Impact factor: 11.205

9.  The BET family of proteins targets moloney murine leukemia virus integration near transcription start sites.

Authors:  Jan De Rijck; Christine de Kogel; Jonas Demeulemeester; Sofie Vets; Sara El Ashkar; Nirav Malani; Frederic D Bushman; Bart Landuyt; Steven J Husson; Katrien Busschots; Rik Gijsbers; Zeger Debyser
Journal:  Cell Rep       Date:  2013-10-31       Impact factor: 9.423

10.  BET-independent MLV-based Vectors Target Away From Promoters and Regulatory Elements.

Authors:  Sara El Ashkar; Jan De Rijck; Jonas Demeulemeester; Sofie Vets; Paradise Madlala; Katerina Cermakova; Zeger Debyser; Rik Gijsbers
Journal:  Mol Ther Nucleic Acids       Date:  2014-07-29       Impact factor: 10.183

View more
  1 in total

Review 1.  Recent advances in gene therapy for lysosomal storage disorders.

Authors:  David Pw Rastall; Andrea Amalfitano
Journal:  Appl Clin Genet       Date:  2015-06-24
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.